NCT04603274

Brief Summary

The aim of this clinical study is to assess the effectiveness of electroacupuncture in reducing the severity of symptoms, in improving limb function, in improving the aesthetic and motor conduction of the median nerve and in reducing its cross-sectional area at the inlet of the carpal tunnel in patients with carpal tunnel syndrome. All upper extremities diagnosed with carpal tunnel syndrome will be treated with electroacupuncture for 8 sessions. Clinical, electrophysiological and ultrasonography outcome measures will be evaluated before and after the intervention, to assess the result.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 26, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

February 1, 2022

Status Verified

January 1, 2022

Enrollment Period

1.5 years

First QC Date

October 18, 2020

Last Update Submit

January 30, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • change from baseline in Symptom Severity Scale (SSS) of -the Greek- Boston carpal tunnel questionnaire (BCTQ)

    The Boston carpal tunnel questionnaire (BCTQ) is an easy, disease-specific measurement of self-reported symptom severity and functional status for carpal tunnel syndrome (CTS). It has two distinct scales, the Symptom Severity Scale (SSS) which has 11 questions and the Functional Status Scale (FSS) containing 8 questions. Each scale using a five-point rating score generates a final score which ranges from 1 to 5, with the higher indicating greater disability. We will use the Greek version of the BCTQ, which had been examined for reliability and validity and responsiveness before and after the intervention.

    3-7 days after the treatment protocol

Secondary Outcomes (9)

  • change from baseline in Functional Status Scale (FSS) of -the Greek- Boston carpal tunnel questionnaire (BCTQ)

    3-7 days after the treatment protocol

  • change from baseline in Visual Analogue Scale (VAS)

    3-7 days after the treatment protocol

  • change from baseline in median sensory nerve conduction velocity (SNCV)

    3-7 days after the treatment protocol

  • change from baseline in median distal motor latency (DML)

    3-7 days after the treatment protocol

  • change from baseline in median sensory nerve action potential (SNAP)

    3-7 days after the treatment protocol

  • +4 more secondary outcomes

Study Arms (1)

upper extremity diagnosed with carpal tunnel syndrome

OTHER

8 sessions of electroacupuncture, 2 days a week for 1 month by experienced physicians

Procedure: 8 sessions of electroacupuncture to the upper limb with carpal tunnel syndrome

Interventions

All participants will accept 8 sessions of electroacupuncture, 2 days a week for 1 month by experienced physicians. Acupuncture sterile disposable needles 0,25x 0,25 mm will be inserted for 20 minutes at specific acupuncture points to all patients. Electrical stimulation will be applied at specific acupuncture points for 20 minutes.

upper extremity diagnosed with carpal tunnel syndrome

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • paraesthesia, numbness, pain in the area of distribution of the median nerve
  • worsening of symptoms at night or with repeated movements of the wrist
  • aesthetic or/and motor deficits in the area of distribution of the median nerve
  • Median sensory nerve conduction velocity (SNCV), first digit to wrist \<42 m/s
  • Median distal motor latency (DML), wrist to thenar eminence \>4 ms.
  • Difference between the median and radial sensory latencies to the thumb ≥ 0,5 ms.
  • Median palmar peak latency (PL)\> 2,2 ms and in comparison to ulnar palmar peak latency ≥ 0,4 ms.
  • Median versus Ulnar - Lumbrical - Interossei studies (Difference between the median 2nd lumbrical \& ulnar 1st palmar interosseous distal latency, \>0,5 ms).

You may not qualify if:

  • age\<18 years
  • absence of the above electrophysiological criteria
  • diagnosis of another disease during the electrophysiological test
  • patients with severe carpal tunnel syndrome to be operated on
  • thenar muscle atrophy
  • previous carpal tunnel release surgery
  • local steroid injections in the last 3 months
  • clinical active rheumatic disease
  • diabetic polyneuropathy
  • alcoholism
  • neurological disease affecting the upper extremity (stroke, multiple sclerosis, amyotrophic lateral sclerosis, cervical radiculopathy, polyneuropathy)
  • contraindications to electroacupuncture: pacemaker, epilepsy, skin disorders in the upper extremities
  • no consent to the study
  • language or communications barriers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pain Clinic of Aretaieion University Hospital

Athens, 11528, Greece

Location

Laboratory of Musculoskeletal Physiotherapy of University of West Attica

Athens, 12243, Greece

Location

Related Publications (11)

  • Bougea A, Zambelis T, Voskou P, Katsika PZ, Tzavara C, Kokotis P, Karandreas N. Reliability and Validation of the Greek Version of the Boston Carpal Tunnel Questionnaire. Hand (N Y). 2018 Sep;13(5):593-599. doi: 10.1177/1558944717725379. Epub 2017 Aug 20.

    PMID: 28825339BACKGROUND
  • Graham B, Peljovich AE, Afra R, Cho MS, Gray R, Stephenson J, Gurman A, MacDermid J, Mlady G, Patel AT, Rempel D, Rozental TD, Salajegheh MK, Keith MW, Jevsevar DS, Shea KG, Bozic KJ, Adams J, Evans JM, Lubahn J, Ray WZ, Spinner R, Thomson G, Shaffer WO, Cummins DS, Murray JN, Mohiuddin M, Mullen K, Shores P, Woznica A, Linskey E, Martinez Y, Sevarino K. The American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on: Management of Carpal Tunnel Syndrome. J Bone Joint Surg Am. 2016 Oct 19;98(20):1750-1754. doi: 10.2106/JBJS.16.00719. No abstract available.

    PMID: 27869627BACKGROUND
  • Jablecki CK, Andary MT, Floeter MK, Miller RG, Quartly CA, Vennix MJ, Wilson JR; American Association of Electrodiagnostic Medicine; American Academy of Neurology; American Academy of Physical Medicine and Rehabilitation. Practice parameter: Electrodiagnostic studies in carpal tunnel syndrome [RETIRED]. Report of the American Association of Electrodiagnostic Medicine, American Academy of Neurology, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2002 Jun 11;58(11):1589-92. doi: 10.1212/wnl.58.11.1589. No abstract available.

    PMID: 12058083BACKGROUND
  • Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, Katz JN. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am. 1993 Nov;75(11):1585-92. doi: 10.2106/00004623-199311000-00002.

    PMID: 8245050BACKGROUND
  • McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988 Nov;18(4):1007-19. doi: 10.1017/s0033291700009934.

    PMID: 3078045BACKGROUND
  • Michopoulos I, Douzenis A, Kalkavoura C, Christodoulou C, Michalopoulou P, Kalemi G, Fineti K, Patapis P, Protopapas K, Lykouras L. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry. 2008 Mar 6;7:4. doi: 10.1186/1744-859X-7-4.

    PMID: 18325093BACKGROUND
  • Milone MT, Karim A, Klifto CS, Capo JT. Analysis of Expected Costs of Carpal Tunnel Syndrome Treatment Strategies. Hand (N Y). 2019 May;14(3):317-323. doi: 10.1177/1558944717743597. Epub 2017 Nov 22.

    PMID: 29166787BACKGROUND
  • Padua L, LoMonaco M, Gregori B, Valente EM, Padua R, Tonali P. Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome hands. Acta Neurol Scand. 1997 Oct;96(4):211-7. doi: 10.1111/j.1600-0404.1997.tb00271.x.

    PMID: 9325471BACKGROUND
  • Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed). 1986 Feb 1;292(6516):344. doi: 10.1136/bmj.292.6516.344. No abstract available.

    PMID: 3080166BACKGROUND
  • Wu IX, Lam VC, Ho RS, Cheung WK, Sit RW, Chou LW, Zhang Y, Leung TH, Chung VC. Acupuncture and related interventions for carpal tunnel syndrome: systematic review. Clin Rehabil. 2020 Jan;34(1):34-44. doi: 10.1177/0269215519877511. Epub 2019 Sep 26.

    PMID: 31556315BACKGROUND
  • Ntoutsouli AM, Georgoudis G, Papapostolou A, Karavis M, Petrou DD, Vadalouca A, Theodoraki K. Effects of electroacupuncture on carpal tunnel syndrome: a clinical, electrophysiological and ultrasonographical pilot study. Acupunct Med. 2025 Aug;43(4):198-207. doi: 10.1177/09645284251363989. Epub 2025 Aug 4.

MeSH Terms

Conditions

Median NeuropathyCarpal Tunnel SyndromePainSomatoform DisordersFibromyalgia

Condition Hierarchy (Ancestors)

MononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersMuscular DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Kassiani Theodoraki, PhD, DESA

    Aretaieion University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology

Study Record Dates

First Submitted

October 18, 2020

First Posted

October 26, 2020

Study Start

July 1, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

February 1, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations